EMPLOYMENT AGREEMENTEmployment Agreement • April 9th, 2021 • Vaccitech PLC • Pharmaceutical preparations • Delaware
This Employment Agreement (“Agreement”) is made by and between Vaccitech Limited (which is anticipated to be reorganized into Vaccitech plc, “Parent”), Vaccitech USA, Inc., a Delaware corporation (the “U.S. Subsidiary”), and Thomas G. Evans, MD (the “Executive”) and is effective as of the closing of the Company’s first underwritten public offering of its equity securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”). Parent, the U.S. Subsidiary, and their respective subsidiaries and other affiliates are collectively referred to herein as the “Company,” and the duties of the Company set forth in this Agreement may be discharged by any entity within that definition. In the interest of clarity, any intercompany transfer shall not be deemed a termination of the employment relationship unless otherwise specified at the time of the transfer.
LICENCE AGREEMENTLicense Agreement • April 9th, 2021 • Vaccitech PLC • Pharmaceutical preparations • England and Wales
Each of Vaccitech, Oxford and OUI is referred to as a “Party” and together as the “Parties”; save that OUI shall only be a Party to this Agreement for the purposes of clause 3.
Clinical Development Partnerships Clinical Trial and Option Agreement Vaccitech Oncology Limited and Cancer Research Technology Limited and Cancer Research UKClinical Trial and Option Agreement • April 9th, 2021 • Vaccitech PLC • Pharmaceutical preparations • England and Wales
Company VACCITECH ONCOLOGY LIMITED (“VOLT”), a company registered in England and Wales under number 11655405 with registered office at The Schrodinger Building 2nd Floor, Heatley Road, Oxford Science Park, Oxford, Oxfordshire, England, OX4 4GE
ContractLicence Agreement • April 9th, 2021 • Vaccitech PLC • Pharmaceutical preparations
CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH “[***]”. SUCH IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS (I) NOT MATERIAL AND (II) THE REGISTRANT CUSTOMARILY AND ACTUALLY TREATS THAT INFORMATION AS PRIVATE OR CONFIDENTIAL.
DATED 8 September 2017License Agreement • April 9th, 2021 • Vaccitech PLC • Pharmaceutical preparations
OXFORD SCIENCES INNOVATION PLC - and - VACCITECH LIMITED LEASE Part of Second Floor, The Schrödinger Building The Oxford Science Park Sandford-on-Thames Oxford 71 Queen Victoria Street London EC4V 4AY Direct Dial +44 (0)20 7395 3047 Direct Fax +44...Lease Agreement • April 9th, 2021 • Vaccitech PLC • Pharmaceutical preparations
LR2. Title Number(s) LR2.1 Landlord’s title number(s) Title number(s) out of which this lease is granted. Leave blank if not registered. LR2.2 Other title numbers Existing title number(s) against which entries of matters referred to in LR9, LR10, LR11 and LR13 are to be made.
